Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity - BioLegacy Research

Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity

Post author:Sam
Post published:July 31, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace